Business Description
Berry Genomics Co Ltd
NAICS : 336390
SIC : 3714
ISIN : CNE000000PN7
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.98 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.62 | |||||
Interest Coverage | 0.22 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.87 | |||||
Beneish M-Score | -3.56 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.9 | |||||
3-Year FCF Growth Rate | 4.9 | |||||
3-Year Book Growth Rate | -7.8 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 67.69 | |||||
9-Day RSI | 63.43 | |||||
14-Day RSI | 58.27 | |||||
6-1 Month Momentum % | -21.51 | |||||
12-1 Month Momentum % | -30.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.02 | |||||
Quick Ratio | 1.74 | |||||
Cash Ratio | 0.36 | |||||
Days Inventory | 139.38 | |||||
Days Sales Outstanding | 312.02 | |||||
Days Payable | 173.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 0.15 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.6 | |||||
Operating Margin % | 0.27 | |||||
Net Margin % | -34.61 | |||||
FCF Margin % | 4.25 | |||||
ROE % | -19.16 | |||||
ROA % | -13.4 | |||||
ROIC % | 0.13 | |||||
ROC (Joel Greenblatt) % | -23.34 | |||||
ROCE % | -18.92 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 49.56 | |||||
PS Ratio | 2.97 | |||||
PB Ratio | 1.75 | |||||
Price-to-Tangible-Book | 1.86 | |||||
Price-to-Free-Cash-Flow | 58.8 | |||||
Price-to-Operating-Cash-Flow | 28.5 | |||||
EV-to-EBIT | -7.79 | |||||
EV-to-EBITDA | -7.79 | |||||
EV-to-Revenue | 2.86 | |||||
EV-to-FCF | 67.26 | |||||
Price-to-Projected-FCF | 4.4 | |||||
Price-to-Median-PS-Value | 0.35 | |||||
Price-to-Net-Current-Asset-Value | 5.34 | |||||
Earnings Yield (Greenblatt) % | -12.84 | |||||
FCF Yield % | 1.49 | |||||
Forward Rate of Return (Yacktman) % | -4.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Berry Genomics Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,150.686 | ||
EPS (TTM) (Â¥) | -1.13 | ||
Beta | 1.29 | ||
Volatility % | 45.88 | ||
14-Day RSI | 58.27 | ||
14-Day ATR (Â¥) | 0.582301 | ||
20-Day SMA (Â¥) | 8.1795 | ||
12-1 Month Momentum % | -30.44 | ||
52-Week Range (Â¥) | 5.4 - 16.48 | ||
Shares Outstanding (Mil) | 353.52 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Berry Genomics Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Berry Genomics Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Berry Genomics Co Ltd Frequently Asked Questions
What is Berry Genomics Co Ltd(SZSE:000710)'s stock price today?
When is next earnings date of Berry Genomics Co Ltd(SZSE:000710)?
Does Berry Genomics Co Ltd(SZSE:000710) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |